Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Radiation Injuries 1Pain 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant mesenchymal tumor 1Liposarcoma 1Hemangiosarcoma 1Head and Neck Neoplasms 1Fibrosarcoma 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma 1

Interventions

Ifosfamide 8Doxorubicin 7Filgrastim 3brostallicin 2Trabectedin 2Radiotherapy, Conformal 2Imatinib Mesylate 2perifosine 1pegfilgrastim 1indolepropanol phosphate 1exatecan 1etoposide phosphate 1X-Rays 1Watchful Waiting 1Vincristine 1Radiotherapy 1Observation 1Mesna 1Mass Spectrometry 1Granulocyte Colony-Stimulating Factor 1Glutamine 1Etoposide 1Dactinomycin 1Cyclophosphamide 1Combined Modality Therapy 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Biopsy 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fibrosarcoma × Glutamine × Clear all
NCT00334984 2013-07-11

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Children's Oncology Group

Phase NA Withdrawn
Sarcoma

Malignant mesenchymal tumor, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Osteosarcoma, Dermatofibrosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡